Description

Patients with Gestational trophoblastic disease (GTD) can be divided into good and poor prognostic groups based on clinical and laboratory findings.


 

Prognostic factors:

(1) duration of disease in months

(2) pretherapy serum HCG

(3) status of metastases

(4) features of preceding pregnancy

 

Prognostic Indicators

Good

Poor

duration in months

<= 4

> 4

pretherapy serum ß-HCG

<= 40,000

> 40,000 IU/L

metastases

neither brain or liver

brain or liver

preceding pregnancy

abortion, ectopic, hydatidiform mole

term pregnancy

previous chemotherapy for the GTD

no

yes

 

Interpretation:

• good prognosis: no poor prognostic indicators found

• poor prognosis: any of the poor prognostic indicators, with worsening of prognosis as number of indicators increases

 


To read more or access our algorithms and calculators, please log in or register.